Expression of cathepsin D in colorectal adenocarcinomas: Correlation with clinicopathologic features

Annals of Saudi Medicine

Volumn 23, Issue 3-4, 2003, Pages 208-211

  Yilmaz, Fahri ^a   Uzunlar, Ali Kemal ^a   Kilinc, Nihal ^a   Yilmaz, Gülsen ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D;

ADULT; ARTICLE; CANCER GRADING; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0041883754     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.208     Document Type: Article

References (23)

1. Theodoropoulos GE, Panoussopoulos D, Larazis ACH, Golematis BCH. Evaluation of Cathepsin D Immunostaining in Colorectal Adenocarcinoma. J Surg Oncol 1997; 65:242-248.
2. Schwartz MK. Tissue cathepsins as tumor markers. Clin Chim Acta 1995; 237:67-78.
3. Aroa J, Fukui H, Ono Y, Ueda Y, Chiba T, Fujimori T. Immunohistochemical localization of cathepsin D in colorectal tumors. Dis Colon Rectum 2000; 43:396-401.
4. Montcourrier P, Mangeat PH, Salazar G, Morisset M, Sahuquet A, Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large vesicles. Cancer Res 1990; 50:6045-54.
5. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 248:67-8.
6. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 1980; 20:353-62.
7. Thorpe SM, Rochefort H, Garcia M, Freiss G, Christensen IJ, Khalaf S, et al. Association between high concentrations of Mr 52.000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 1989; 49:6008-14.
8. Spyratos F, Maudelonde T, Brouillet GB, Brunet M, Defrenne A, Andrieu C, et al. Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 1989; 2:1115-8.
9. Kute TE, Shao ZM, Sugg NK, Long RT, Russell GB, Case LD.. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassay and enzymatic assays. Cancer Res 1992; 52:5198-203.
10. Ioachim EE, Goussia AC, Machera M, Tsianos EV, Kappas AM, Agnantis NJ. Immunohistochemical evaluation of cathepsin D in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Anticancer Research 1999; 19:2147-56.
11. Agarwal S. Protease cathepsins-A view. Biochem Educ 1990; 18:67-72.
12. Briozzo P, Morriset M, Capony F, Rougeot C, Rochefort H. In vitro degradation of extracellular matrix with Mr 52.000 Cathepsin D secreted by breast cancer cells. Cancer Res 1988; 48:3388-92.
13. Briozzo P, Badet J, Capony F, Piery I, Montcourrer P, Barritault D, et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991; 194:252-59.
14. Galandiuk S, Mireljic S, Yang AR, Early M, McCoy MD, Wittliff JL. Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease. Arch Surg 1993; 128-637-42.
15. Valentini AM, Pirelli H, Armentano R, Caruso ML. The immunohistochemical expression of cathepsin D in colorectal cancer. Anticancer Res 1996; 16:77-80.
16. Valentini AM, Amati L, Pirelli M, Armentano R, Caruso ML. Immunohistochemical expression of pS2 and cathepsin D in breast cancer relationship with ER, PgR immunostaining and clinicopathologic aspects. Oncol Rep 1994; 1:585-90.
17. Sheahan K, Shuja S, Murnane MJ. Cystein protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989; 49:3809-14.
18. Tumminello FM, Gebbia N, Pizzolanti G, Russo A, Bazan V, Leto G. Cathepsin D content in colorectal cancer. Oncology 1995; 52:237-42.
19. Mayer A, Fritz E, Fortelny R, Kofler K, Ludwig H. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer. Cancer Invest 1997; 15:106-10.
20. Augereau P, Garcia M, Mattei MG, Cavailles V, Depadova F, Derocq D, et al. Cloning and sequencing of the 52 K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer and mapping on chromosome 11. Mol Endocrinol 1988;2:186-92.
21. Theodoropoulos GE, Lazaris AC, Panoussopoulos D, Davaris P, Golematis BC. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma. J Surg Oncol 1995; 58:176-83.
22. Henry JA, McCarthy AL, Angus B, Westley BR, May FE, Nicholson S, et al. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: An immunohistochemical study. Cancer 1990; 65:265-71.
23. Rogers S, Day CA, Fox SB. Expression of cathepsin D and estrogen receptor in male breast carcinoma. Hum Pathol 1993; 24:148-51.